nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP2D6—Parkinson's disease	0.858	1	CbGaD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000201	0.00142	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GSTM1—Parkinson's disease	0.000198	0.0014	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000197	0.0014	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—DDC—Parkinson's disease	0.000197	0.00139	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000196	0.00138	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000195	0.00138	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—DDC—Parkinson's disease	0.000194	0.00137	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP2E1—Parkinson's disease	0.000189	0.00133	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000186	0.00132	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTA4—Parkinson's disease	0.000186	0.00131	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTA4—Parkinson's disease	0.000183	0.00129	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000181	0.00128	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00017	0.0012	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PLA2G6—Parkinson's disease	0.000167	0.00118	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MAOB—Parkinson's disease	0.000166	0.00117	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000165	0.00117	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PLA2G6—Parkinson's disease	0.000165	0.00116	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MAOB—Parkinson's disease	0.000163	0.00115	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000159	0.00112	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—COMT—Parkinson's disease	0.000156	0.00111	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000156	0.0011	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GSTP1—Parkinson's disease	0.000156	0.0011	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.000155	0.0011	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.000154	0.00109	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000153	0.00109	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000152	0.00108	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000145	0.00103	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000145	0.00102	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000143	0.00101	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.000143	0.00101	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000143	0.00101	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000141	0.000997	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ND3—Parkinson's disease	0.00014	0.000992	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MCCC1—Parkinson's disease	0.00014	0.000992	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000136	0.000961	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000134	0.000949	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000133	0.000941	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000132	0.000936	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000132	0.000936	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—OMD—Parkinson's disease	0.000132	0.000933	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TALDO1—Parkinson's disease	0.000132	0.000933	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000131	0.000928	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000129	0.000913	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000127	0.000898	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NDUFB11—Parkinson's disease	0.000125	0.000884	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP2D6—Parkinson's disease	0.000123	0.00087	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000122	0.00086	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP2D6—Parkinson's disease	0.000121	0.000857	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CTGF—Parkinson's disease	0.000121	0.000854	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GCH1—Parkinson's disease	0.000119	0.000843	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CTGF—Parkinson's disease	0.000119	0.000841	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP2E1—Parkinson's disease	0.000113	0.000796	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NQO1—Parkinson's disease	0.000111	0.000787	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000111	0.000787	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000111	0.000786	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP2E1—Parkinson's disease	0.000111	0.000784	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000111	0.000783	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.00011	0.000781	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.00011	0.000779	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.00011	0.000776	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—TH—Parkinson's disease	0.00011	0.000776	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.00011	0.000775	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NQO1—Parkinson's disease	0.00011	0.000775	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000109	0.000774	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000109	0.000772	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000109	0.000769	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000108	0.000765	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—TH—Parkinson's disease	0.000108	0.000764	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000107	0.000755	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GBA—Parkinson's disease	0.000106	0.000752	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—DBH—Parkinson's disease	0.000106	0.000752	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—FBP1—Parkinson's disease	0.000106	0.000752	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYCS—Parkinson's disease	0.000105	0.000745	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYCS—Parkinson's disease	0.000104	0.000733	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000102	0.000719	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.000101	0.000717	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ND3—Parkinson's disease	0.000101	0.000717	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000101	0.000713	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.0001	0.000709	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	9.94e-05	0.000703	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	9.59e-05	0.000678	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TALDO1—Parkinson's disease	9.53e-05	0.000674	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—OMD—Parkinson's disease	9.53e-05	0.000674	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.46e-05	0.000669	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—COMT—Parkinson's disease	9.32e-05	0.000659	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.28e-05	0.000657	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTP1—Parkinson's disease	9.28e-05	0.000656	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MAOA—Parkinson's disease	9.26e-05	0.000655	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—COMT—Parkinson's disease	9.18e-05	0.000649	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—HMOX1—Parkinson's disease	9.15e-05	0.000647	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTP1—Parkinson's disease	9.14e-05	0.000646	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MAOA—Parkinson's disease	9.12e-05	0.000645	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	9.03e-05	0.000639	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—HMOX1—Parkinson's disease	9.01e-05	0.000637	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.91e-05	0.00063	CbGpPWpGaD
Zalcitabine—Gemcitabine—ABCB1—Parkinson's disease	8.86e-05	0.524	CrCbGaD
Zalcitabine—DCK—Metabolism—ABCB1—Parkinson's disease	8.78e-05	0.000621	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	8.77e-05	0.00062	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ABCB1—Parkinson's disease	8.65e-05	0.000612	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.65e-05	0.000612	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GCH1—Parkinson's disease	8.62e-05	0.00061	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTM1—Parkinson's disease	8.53e-05	0.000603	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTM1—Parkinson's disease	8.4e-05	0.000594	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GPX1—Parkinson's disease	8.16e-05	0.000578	CbGpPWpGaD
Zalcitabine—Lamivudine—ABCB1—Parkinson's disease	8.06e-05	0.476	CrCbGaD
Zalcitabine—CYP3A43—Metabolism—GPX1—Parkinson's disease	8.04e-05	0.000569	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—DDC—Parkinson's disease	7.8e-05	0.000552	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GBA—Parkinson's disease	7.68e-05	0.000543	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—FBP1—Parkinson's disease	7.68e-05	0.000543	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—DBH—Parkinson's disease	7.68e-05	0.000543	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.59e-05	0.000537	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MTHFR—Parkinson's disease	7.54e-05	0.000533	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MTHFR—Parkinson's disease	7.42e-05	0.000525	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTA4—Parkinson's disease	7.37e-05	0.000521	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.27e-05	0.000514	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.23e-05	0.000512	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.22e-05	0.00051	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ND3—Parkinson's disease	7.21e-05	0.00051	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	7.21e-05	0.00051	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.17e-05	0.000507	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	7.15e-05	0.000505	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ND3—Parkinson's disease	7.15e-05	0.000505	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.13e-05	0.000505	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—APOE—Parkinson's disease	7.01e-05	0.000496	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—APOE—Parkinson's disease	6.91e-05	0.000489	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.78e-05	0.000479	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—OMD—Parkinson's disease	6.78e-05	0.000479	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—OMD—Parkinson's disease	6.72e-05	0.000475	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	6.72e-05	0.000475	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.65e-05	0.00047	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	6.63e-05	0.000469	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MAOB—Parkinson's disease	6.57e-05	0.000464	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.55e-05	0.000464	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.42e-05	0.000454	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	6.37e-05	0.000451	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.13e-05	0.000434	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCH1—Parkinson's disease	6.08e-05	0.00043	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—INS—Parkinson's disease	5.99e-05	0.000424	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—INS—Parkinson's disease	5.9e-05	0.000418	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—DDC—Parkinson's disease	5.64e-05	0.000399	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.48e-05	0.000388	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GBA—Parkinson's disease	5.46e-05	0.000386	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.46e-05	0.000386	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—DBH—Parkinson's disease	5.46e-05	0.000386	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—DBH—Parkinson's disease	5.41e-05	0.000383	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GBA—Parkinson's disease	5.41e-05	0.000383	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—FBP1—Parkinson's disease	5.41e-05	0.000383	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTA4—Parkinson's disease	5.32e-05	0.000377	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	4.88e-05	0.000345	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	4.79e-05	0.000339	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CTGF—Parkinson's disease	4.79e-05	0.000339	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MAOB—Parkinson's disease	4.75e-05	0.000336	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ND3—Parkinson's disease	4.71e-05	0.000333	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.71e-05	0.000333	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	4.46e-05	0.000316	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.43e-05	0.000313	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—OMD—Parkinson's disease	4.43e-05	0.000313	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NQO1—Parkinson's disease	4.41e-05	0.000312	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TH—Parkinson's disease	4.35e-05	0.000308	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.2e-05	0.000297	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYCS—Parkinson's disease	4.18e-05	0.000295	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—DDC—Parkinson's disease	4.01e-05	0.000284	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.01e-05	0.000283	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—DDC—Parkinson's disease	3.97e-05	0.000281	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.79e-05	0.000268	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	3.75e-05	0.000266	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.71e-05	0.000262	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—COMT—Parkinson's disease	3.7e-05	0.000262	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTP1—Parkinson's disease	3.68e-05	0.00026	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MAOA—Parkinson's disease	3.67e-05	0.00026	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMOX1—Parkinson's disease	3.63e-05	0.000257	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GBA—Parkinson's disease	3.57e-05	0.000253	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.57e-05	0.000253	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—DBH—Parkinson's disease	3.57e-05	0.000253	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	3.53e-05	0.00025	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCB1—Parkinson's disease	3.48e-05	0.000246	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CTGF—Parkinson's disease	3.46e-05	0.000245	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.41e-05	0.000241	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—Parkinson's disease	3.38e-05	0.000239	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.38e-05	0.000239	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.37e-05	0.000239	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.35e-05	0.000237	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPX1—Parkinson's disease	3.24e-05	0.000229	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	3.23e-05	0.000228	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NQO1—Parkinson's disease	3.19e-05	0.000226	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.18e-05	0.000225	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TH—Parkinson's disease	3.14e-05	0.000222	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYCS—Parkinson's disease	3.02e-05	0.000214	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—Parkinson's disease	2.99e-05	0.000211	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOE—Parkinson's disease	2.78e-05	0.000197	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—COMT—Parkinson's disease	2.67e-05	0.000189	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—Parkinson's disease	2.66e-05	0.000188	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MAOA—Parkinson's disease	2.65e-05	0.000188	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.62e-05	0.000186	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—DDC—Parkinson's disease	2.62e-05	0.000185	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.52e-05	0.000178	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.49e-05	0.000176	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.48e-05	0.000175	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.46e-05	0.000174	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.44e-05	0.000173	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.44e-05	0.000173	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—INS—Parkinson's disease	2.38e-05	0.000168	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.34e-05	0.000166	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.29e-05	0.000162	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.27e-05	0.000161	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.27e-05	0.00016	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.25e-05	0.000159	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TH—Parkinson's disease	2.24e-05	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.23e-05	0.000158	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TH—Parkinson's disease	2.22e-05	0.000157	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.21e-05	0.000156	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.16e-05	0.000153	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.15e-05	0.000152	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.13e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOE—Parkinson's disease	2.01e-05	0.000142	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.9e-05	0.000134	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.89e-05	0.000134	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.89e-05	0.000134	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—COMT—Parkinson's disease	1.88e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.88e-05	0.000133	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.87e-05	0.000132	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.87e-05	0.000132	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.85e-05	0.000131	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.79e-05	0.000127	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.78e-05	0.000126	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.74e-05	0.000123	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.72e-05	0.000122	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—INS—Parkinson's disease	1.72e-05	0.000122	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.66e-05	0.000118	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.65e-05	0.000117	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.64e-05	0.000116	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.61e-05	0.000114	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.54e-05	0.000109	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.52e-05	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.5e-05	0.000106	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.48e-05	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TH—Parkinson's disease	1.46e-05	0.000103	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.43e-05	0.000101	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOE—Parkinson's disease	1.42e-05	0.0001	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.4e-05	9.93e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.24e-05	8.79e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.24e-05	8.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.23e-05	8.73e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—INS—Parkinson's disease	1.22e-05	8.64e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.22e-05	8.63e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—INS—Parkinson's disease	1.21e-05	8.57e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.17e-05	8.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.14e-05	8.04e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.09e-05	7.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1e-05	7.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOE—Parkinson's disease	9.35e-06	6.62e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—INS—Parkinson's disease	7.99e-06	5.65e-05	CbGpPWpGaD
